GI
TYRA icon

GAMMA Investing’s Tyra Biosciences TYRA Stock Holding History

GAMMA Investing’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.88K Sell
452
-53
-10% -$1.46K ﹤0.01% 3338
2026
Q2 		$16.1K Sell
505
-1
-0.2% -$33 ﹤0.01% 2960
2026
Q1 		$19.4K Buy
506
+34
+7% +$1.1K ﹤0.01% 2728
2025
Q4 		$12.4K Buy
472
+161
+52% +$2.96K ﹤0.01% 2871
2025
Q3 		$4.35K Buy
311
+96
+45% +$1.09K ﹤0.01% 3233
2025
Q2 		$2.06K Buy
+215
New +$2.04K ﹤0.01% 3391
2025
Q1 		– Sell
-26
Closed -$361 – 3884
2024
Q4 		$361 Sell
26
-57
-69% -$1.03K ﹤0.01% 3634
2024
Q3 		$1.95K Buy
83
+48
+137% +$1.01K ﹤0.01% 3075
2024
Q2 		$560 Buy
35
+19
+119% +$327 ﹤0.01% 3191
2024
Q1 		$262 Hold
16
– – ﹤0.01% 3201
2023
Q4 		$214 Buy
+16
New +$207 ﹤0.01% 3114

Other funds holding TYRA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's TYRA Position: Q3 2026 in Review

GAMMA Investing reduced its Tyra Biosciences (TYRA) stake by 10% in Q3 2026, selling an estimated $1.46K and leaving 452 shares worth $9.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

GAMMA Investing first reported a position in TYRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.4K in Q1 2026. 3 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • GAMMA Investing held 452 shares of Tyra Biosciences worth $9.88K as of Q3 2026.
  • GAMMA Investing sold 53 Tyra Biosciences shares in Q3 2026, an estimated $1.46K.
  • Tyra Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3338 holding.
  • GAMMA Investing first reported a position in Tyra Biosciences in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Tyra Biosciences position peaked at $19.4K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.